Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

MeVis Medical Solutions AG

M3V
Current price
24 EUR -0.2 EUR (-0.83%)
Last closed 24.2 EUR
ISIN DE000A0LBFE4
Sector Healthcare
Industry Health Information Services
Exchange Frankfurt Exchange
Capitalization 44 241 253 EUR
Yield for 12 month -5.47 %
1Y
3Y
5Y
10Y
15Y
M3V
21.11.2021 - 28.11.2021

MeVis Medical Solutions AG develops, markets, and sells software for recording, analyzing, and evaluating image data to manufacturers of medical devices, providers of medical IT platforms, and clinical end customers in the United States and Europe. The company's clinical focuses are image-based early detection and diagnosis of epidemiologically important diseases, such as breast, lung, liver, and neurological diseases. It offers X-ray based radiography procedures, including computed tomography, mammography/digital tomosynthesis, magnetic resonance imaging, and digital sonography; and provides services in the field of software programming for medical technology companies, which comprise provision of software developers, product and project managers, application specialists, and test engineers. The company also offers three-dimensional technical visualizations; and interactive online training to enhance the diagnostic skills of clinicians, as well as internet-based special applications in teleradiology. In addition, it develops and sells software licenses; and provides services for technical visualization and online training. The company was incorporated in 1997 and is based in Bremen, Germany. MeVis Medical Solutions AG is a subsidiary of Varex Imaging Deutschland AG. Address: Caroline-Herschel-Str. 1, Bremen, Germany, 28359

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

P/E ratio

7.6582

Dividend Yield

4 %

Current Year

+17 419 666 EUR

Last Year

+18 846 026 EUR

Current Quarter

+4 406 853 EUR

Last Quarter

+4 406 853 EUR

Current Year

+16 972 427 EUR

Last Year

+18 096 118 EUR

Current Quarter

+1 733 179 EUR

Last Quarter

+1 733 179 EUR

Key Figures M3V

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA 4 846 426 EUR
Operating Margin TTM 26.25 %
PE Ratio 7.6582
Return On Assets TTM 11.94 %
PEG Ratio
Return On Equity TTM 32.27 %
Wall Street Target Price
Revenue TTM 17 723 087 EUR
Book Value 9.84 EUR
Revenue Per Share TTM
Dividend Share 0.95 EUR
Quarterly Revenue Growth YOY 3.6 %
Dividend Yield 4 %
Gross Profit TTM 8 631 822 EUR
Earnings per share 3.17 EUR
Diluted Eps TTM 3.17 EUR
Most Recent Quarter I 2024
Quarterly Earnings Growth YOY 45.5 %
Profit Margin 32.6 %

Dividend Analytics M3V

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

28 %

Dividend History M3V

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate 0.95
Ex Dividend Date 20.03.2024
Forward Annual Dividend Yield 3.93 %
Last Split Factor
Payout Ratio 30.06 %
Last Split Date
Dividend Date

Stock Valuation M3V

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE 7.6582
Forward PE
Enterprise Value Revenue 2.2201
Price Sales TTM 2.4962
Enterprise Value EBITDA 7.7644
Price Book MRQ 2.4708

Financials M3V

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators M3V

For 52 weeks

22.23 EUR 26.92 EUR
50 Day MA 23.91 EUR
Shares Short Prior Month
200 Day MA 25.18 EUR
Short Ratio
Shares Short
Short Percent